Icecure Medical Q4 EPS $(0.06) Misses $(0.04) Estimate, Sales $1.279M Miss $1.900M Estimate

Icecure Medical (NASDAQ: ICCM) reported Q4 losses of $(0.06) per share, missing the analyst estimate of $(0.04) by 33.33%. This reflects a 25% improvement over losses of $(0.08) per share from the same period last year. The company's quarterly sales were $1.279 million, falling short of the $1.900 million estimate by 32.68%, but representing a 46.17% increase from $875,000 in the previous year.